The National Science Foundation awarded a $100,000 grant to Parabon NanoLabs, a subsidiary of Parabon Computation, to develop cancer treatments using its DNA nanotechnology fabrication and grid computing sequence optimization. Parabon's research will focus on novel anti-cancer molecules that have the ability to self-assemble from interlocking strands of synthetic DNA.

Related Summaries